(Q37767980)

22 August 2017

1 reference

title

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management (English)

1 reference

Duchenne muscular dystrophy

22 August 2017

main subject

1 reference

Richard T Moxley

1

1 reference

22 August 2017

Shree Pandya

2

1 reference

22 August 2017

Emma Ciafaloni

3

1 reference

22 August 2017

Deborah J Fox

4

1 reference

22 August 2017

Kim Campbell

5

1 reference

22 August 2017

language of work or name

1 reference

25 June 2010

1 reference

Journal of Child Neurology

22 August 2017

published in

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

9

1 reference

22 August 2017

page(s)

1116-1129

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Managing Duchenne muscular dystrophy--the additive effect of spinal surgery and home nocturnal ventilation in improving survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Current treatment of adult Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Adult life with Duchenne muscular dystrophy: observations among an emerging and unforeseen patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073810371004

21 January 2018

Identifiers

DOI

10.1177/0883073810371004

1 reference

22 August 2017

1 reference